OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?
Philippe Devillier, P. Démoly, Mathiéu Molimard
Expert Review of Respiratory Medicine (2020) Vol. 14, Iss. 5, pp. 445-452
Open Access | Times Cited: 23
Philippe Devillier, P. Démoly, Mathiéu Molimard
Expert Review of Respiratory Medicine (2020) Vol. 14, Iss. 5, pp. 445-452
Open Access | Times Cited: 23
Showing 23 citing articles:
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
Oliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 10
Oliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 10
Real-World Study: Drug Reduction in Children With Allergic Rhinitis and Asthma Receiving Immunotherapy
Jorge Sánchez, Leidy Álvarez, Elizabeth García
Immunotherapy (2023) Vol. 15, Iss. 4, pp. 253-266
Closed Access | Times Cited: 7
Jorge Sánchez, Leidy Álvarez, Elizabeth García
Immunotherapy (2023) Vol. 15, Iss. 4, pp. 253-266
Closed Access | Times Cited: 7
Allergic asthma: An indication for allergen immunotherapy
Tobias Ankermann, Randolf Brehler
Allergologie select (2023) Vol. 7, Iss. 1, pp. 33-38
Open Access | Times Cited: 7
Tobias Ankermann, Randolf Brehler
Allergologie select (2023) Vol. 7, Iss. 1, pp. 33-38
Open Access | Times Cited: 7
A review of allergen immunotherapy in asthma
Davide Caimmi, P. Démoly
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 4, pp. 310-313
Closed Access | Times Cited: 10
Davide Caimmi, P. Démoly
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 4, pp. 310-313
Closed Access | Times Cited: 10
Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies
Oliver Pfaar, Philippe Devillier, Jochen Schmitt, et al.
Allergy (2023) Vol. 78, Iss. 8, pp. 2277-2289
Open Access | Times Cited: 6
Oliver Pfaar, Philippe Devillier, Jochen Schmitt, et al.
Allergy (2023) Vol. 78, Iss. 8, pp. 2277-2289
Open Access | Times Cited: 6
Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 881-883
Open Access | Times Cited: 13
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 881-883
Open Access | Times Cited: 13
Real-life studies in allergen immunotherapy
Giovanni Passalacqua, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 4, pp. 361-367
Closed Access | Times Cited: 11
Giovanni Passalacqua, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 4, pp. 361-367
Closed Access | Times Cited: 11
Long‐term effects of pollen allergoid tyrosine‐adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma
Christian Vogelberg, Ludger Klimek, Silvia Kruppert, et al.
Clinical & Experimental Allergy (2023) Vol. 54, Iss. 4, pp. 253-264
Open Access | Times Cited: 4
Christian Vogelberg, Ludger Klimek, Silvia Kruppert, et al.
Clinical & Experimental Allergy (2023) Vol. 54, Iss. 4, pp. 253-264
Open Access | Times Cited: 4
House dust mite immunotherapy: A real‐world, prescription data‐based analysis
Ralph Mösges, Hartmut Richter, A. Sager, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Ralph Mösges, Hartmut Richter, A. Sager, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Controversies in Allergy: A Pro/Con Review of Sublingual Allergen Immunotherapy and Allergic Asthma
Moisés A. Calderón, Leonard B. Bacharier
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1818-1825
Closed Access | Times Cited: 10
Moisés A. Calderón, Leonard B. Bacharier
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1818-1825
Closed Access | Times Cited: 10
Recommandations pour la prescription de l’immunothérapie allergénique et le suivi du patient — Questions développées et revue de la littérature
Davide Caimmi, P. Démoly
Revue française d'allergologie (2020) Vol. 61, Iss. 1, pp. 35-56
Closed Access | Times Cited: 6
Davide Caimmi, P. Démoly
Revue française d'allergologie (2020) Vol. 61, Iss. 1, pp. 35-56
Closed Access | Times Cited: 6
Real-world safety and effectiveness evidence of a microcrystalline tyrosine-associated mite allergoid in children and adolescents with allergic rhinitis
Anna Sala, Zulay M Almeida-Sánchez, I García-Núñez, et al.
Allergologia et Immunopathologia (2021) Vol. 49, Iss. 4, pp. 98-108
Open Access | Times Cited: 6
Anna Sala, Zulay M Almeida-Sánchez, I García-Núñez, et al.
Allergologia et Immunopathologia (2021) Vol. 49, Iss. 4, pp. 98-108
Open Access | Times Cited: 6
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Philippe Devillier, Mathiéu Molimard, Jean‐François Bergmann, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 405-412
Open Access | Times Cited: 2
Philippe Devillier, Mathiéu Molimard, Jean‐François Bergmann, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 405-412
Open Access | Times Cited: 2
Safety and Effectiveness of a Microcrystalline Tyrosine-Associated Mite Extract Immunotherapy for Allergic Rhinitis
Anna Sala, J. L. Pérez‐Formoso, Carla Torán‐Barona, et al.
Immunotherapy (2020) Vol. 12, Iss. 13, pp. 1007-1019
Closed Access | Times Cited: 4
Anna Sala, J. L. Pérez‐Formoso, Carla Torán‐Barona, et al.
Immunotherapy (2020) Vol. 12, Iss. 13, pp. 1007-1019
Closed Access | Times Cited: 4
Real world study of grass pollen immunotherapy—Similar efficacy of SCIT and SLIT
Lone Winther, Anne Caroline Curtz, Zsuzsa Domokos
Allergy (2024) Vol. 79, Iss. 8, pp. 2280-2282
Closed Access
Lone Winther, Anne Caroline Curtz, Zsuzsa Domokos
Allergy (2024) Vol. 79, Iss. 8, pp. 2280-2282
Closed Access
Retrospective, Real Life Study on the Effectiveness and Safety of a Depigmented-Polymerized Subcutaneous Vaccine Containing a Mixture of Grasses and <i>Olea europaea</i>
Ana Montero, David Sanz‐Rosa, Jerónimo Carnés
International Archives of Allergy and Immunology (2024), pp. 1-8
Closed Access
Ana Montero, David Sanz‐Rosa, Jerónimo Carnés
International Archives of Allergy and Immunology (2024), pp. 1-8
Closed Access
Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Allergy (2024)
Closed Access
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Allergy (2024)
Closed Access
B cells modulate mouse allergen-specific T cells in nonallergic laboratory animal-care workers
Esther Dawen Yu, Luise Westernberg, Alba Grifoni, et al.
JCI Insight (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 3
Esther Dawen Yu, Luise Westernberg, Alba Grifoni, et al.
JCI Insight (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 3
Update about Oralair® as a treatment for grass pollen allergic rhinitis
Ludger Klimek, Randolf Brehler, Ralph Mösges, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 2
Ludger Klimek, Randolf Brehler, Ralph Mösges, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 2
Use of real‐world evidence in translational pharmacology research
Mathieu Charvériat, Stéfan Darmoni, Vincent Lafon, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 2, pp. 230-236
Closed Access | Times Cited: 2
Mathieu Charvériat, Stéfan Darmoni, Vincent Lafon, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 2, pp. 230-236
Closed Access | Times Cited: 2
Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study
Mario Di Gioacchino, Loredana Della Valle, Rocco Mangifesta, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7384-7384
Open Access | Times Cited: 1
Mario Di Gioacchino, Loredana Della Valle, Rocco Mangifesta, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7384-7384
Open Access | Times Cited: 1
